Tag: N.V

Immatics N.V. (IMTX) Seeing Strong Enrollment in a Key Phase 3 Trial of Drug Candidate

Immatics N.V. (NASDAQ:IMTX) has recently been highlighted as one of the best German stocks to buy according to

Nebius Group N.V. (NBIS) Slid Along with Broader Selloff of AI Infrastructure-Related Equities

Fred Alger Management, an investment management company, recently released its fourth-quarter 2025 investor letter for the Alger Small

Parnassus Growth Equity Fund Sold Its Stake in Adyen N.V. (ADYEY)

Parnassus Investments, an investment management company, recently shared its first-quarter 2025 investor letter detailing the performance of the